Kiniksa Pharmaceuticals International, plc (KNSA)
Nasdaq: KNSA · Pharmaceutical Preparations · London · filing with the SEC since 2018
Grade7.2
◀ Past 7.8● Present 7.7▶ Future 5.7
Who runs Kiniksa Pharmaceuticals International, plc
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Patel Sanj K
CHAIRMAN & CEO. First filing May 2018, latest Nov 6, 2026, 17 filings in all.
Officers reporting now
7
of 19 people with a filing in the last fifteen months
Directors reporting now
12
27 people on the record since 2018
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Feb 2020 | Nov 12, 2026 | 10 · $5.2M |
| Patel Sanj K | CHAIRMAN & CEO | May 2018 | Nov 6, 2026 | 28 · $81.1M |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Dec 2020 | Nov 3, 2026 | 11 · $8.9M |
| Moat Ross | CHIEF OPERATING OFFICER | Apr 2021 | Nov 3, 2026 | 13 · $9.8M |
| Paolini John F. | CHIEF MEDICAL OFFICER | May 2018 | Nov 3, 2026 | 15 · $13.9M |
| Malkani Dhiraj H | CHIEF STRATEGY OFFICER | Jul 2026 | Jul 6, 2026 | none |
| Tessari Eben | CHIEF STRATEGY OFFICER | Jun 2021 | Apr 8, 2026 | 4 · $1.0M |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Quart Barry D | director | May 2018 | Aug 21, 2026 | 8 · $2.7M |
| Levy Richard S | director | Mar 2019 | Aug 4, 2026 | none |
| Cole G Bradley | director | Jul 2020 | Jul 31, 2026 | 1 · $300,000 |
| 667, L.P. | director | May 2018 | Jun 2, 2026 | none |
| Baker Bros. Advisors (Gp) LLC | director | May 2018 | Jun 2, 2026 | none |
| Baker Bros. Advisors LP | director | May 2018 | Jun 2, 2026 | none |
| Baker Brothers Life Sciences LP | director | May 2018 | Jun 2, 2026 | none |
| Baker Felix | director | May 2018 | Jun 2, 2026 | none |
| Baker Julian | director | May 2018 | Jun 2, 2026 | none |
| Malley Thomas | director | May 2018 | Jun 2, 2026 | none |
| Mccain Tracey L | director | May 2018 | Jun 2, 2026 | none |
| Popovits Kimberly J | director | May 2018 | Jun 2, 2026 | none |
Earlier names on the record18, newest filing first
Boyd Meta Cantey · director · last filing Oct 2024Pano Arian · officer · last filing Sep 2021Beetham Thomas W. · officer · last filing Mar 2021Rizvi Qasim · officer · last filing Jan 2021Mahoney Stephen F. · officer · last filing Sep 2019Heberlig Chris · officer · last filing Sep 2019Chen Bihua · director · last filing May 2018Cormorant Asset Management, LP · 10% owner · last filing May 2018Cormorant Global Healthcare Gp, LLC · 10% owner · last filing May 2018Cormorant Global Healthcare Master Fund, LP · 10% owner · last filing May 2018Deerfield Management Company, L.P. (Series C) · 10% owner · last filing May 2018Deerfield Mgmt L.P. · 10% owner · last filing May 2018Deerfield Partners, L.P. · 10% owner · last filing May 2018Deerfield Special Situations Fund, L.P. · 10% owner · last filing May 2018Flynn James E · 10% owner · last filing May 2018Boess Carsten · 10% owner · last filing May 2018Biggar Stephen R · director · last filing May 2018Cormorant Private Healthcare Fund I, LP · 10% owner · last filing May 2018
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.